Navigation Links
Gene Therapy shows promise in treating Hemophilia

Researchers at Beth Israel Deaconess Medical Center reported in the current New England Journal of Medicine that an experimental Gene Therapy method has safely introduced new genes into six men suffering from hemophilia. This method shows signs of helping these men fight the disease by producing the blood clotting protein they lack. None of the patients suffers side effects even after one year of the treatment.

The study was designed only to test the safety and not the effectiveness of the treatment of hemophilia. This disease is genetically transmitted and is characterised by excessive bleeding. Researchers belive this study could some day be applied to treat other diseases such as diabetes. For thousands of hemophiliacs around the world, this treatment using gene therapy will come as a life saving blessing.

However the researchers are cautious and feel more examination is necessary before the method can be declared safe. Further studies are on to cross check that the cells inserted as a part of this method into the patients body do not cause the reaction or turn malignant. The next step is to look for ways to produce more clotting factor consistently.
'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. "Make AIDS Therapy affordable" - Physicians demand
4. Hormone replacement Therapy a headache
5. Simple Therapy
6. Therapy for stopping the spread of cancer cells
7. Gene Therapy Destroys Pancreatic Cancer Cells
8. Letrozole Beats Tamoxifen in Breast Cancer Therapy
9. Garlic Supplements Impede HIV Therapy
10. Gene Therapy For Cystic Fibrosis
11. A new study surpasses Gene Therapy Hurdle
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... , ... April 24, 2017 , ... ... designed to recognize elevated anxiety levels in people with addiction who are served ... Smart Patch, a biosensing wearable device that monitors heart and breath rates to ...
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... ... ... “The Saint with Trin, and Omega Station”: a triple feature offering nonstop action ... author, Chris Jackson. Chris Jackson grew up in Abilene, Texas. He now ... teaching English. He is heavily involved in the youth group of his local church. ...
(Date:4/24/2017)... ... , ... A 2-in-1 bottleless water appliance provides both purified ... Texas, here are the ways in which this technology can benefit dental offices: ... fresh, oxygenated water, with both cold and hot options. , Convenience for Dentists ...
(Date:4/22/2017)... NY (PRWEB) , ... April 22, 2017 , ... ... which shows that U.S. consumers can save an average of 70% when buying ... savings (up to 97%) are available when purchasing from other countries. The report ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: